Your Messages Inbox (38) 
Your Unread Messages
See All
Tracy Hampton, PhD
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease 3. Rapid correction of low vitamin D status in nursing home residents 4. 2008 Exclusive Survey—Earnings: Good news for primary care income 5. Medicare pay-for-reporting effort draws fire from frustrated doctors
Your Article Summary
Harnessing the weight-regulating properties of glucagon-like peptide-1 in the treatment of type 2 diabetes
Diabetes, Obesity and Metabolism, 11/06/09
Sesti G et al. – The aim of this article was to review the existing preclinical and clinical evidences, showing that the family of glucagon–like peptide–1 (GLP–1)–based therapies fulfils these criteria by harnessing the beneficial properties of GLP–1, a naturally occurring incretin hormone with a strong blood glucose–lowering action and the ability to induce weight loss.
Today in Diabetes...keeping you current
Receive free subspecialty "5-minute updates" via email
Hemoglobin A1C and diabetes diagnosis: The Rancho Bernardo Study
Diabetes Care, 10/28/09
Carbohydrate-restricted diets for obesity and related diseases: An update
Current Atherosclerosis Reports, 11/17/09
Effects of Walnut Consumption on Endothelial Function in Type 2 Diabetics: A Randomized, Controlled, Cross-Over Trial
Diabetes Care, 11/04/09
Sponsor
Article Search
Sponsor